Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pearson

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Clinical and Experimental Immunology|October 1, 1972
Evaluation of cell mediated immune responses in untreated cases of leprosyG P Talwar, A D Krishnan, V L Mehra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2017
A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry ResearchM A Addicott, J M Pearson, M M Sweitzer, et al.
Leprosy Review|December 1, 1977
Dapsone alone compared with dapsone plus rifampicin in short-term therapy of lepromatous leprosyR H Gelber, M F Waters, J M Pearson, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|January 1, 1976
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studiesR J Rees, M F Waters, J M Pearson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinomaP D Ainsworth, J H R Winstanley, J M Pearson, et al.
The Bone & Joint Journal|May 1, 2019
Combined total hip and knee arthroplasty during the same hospital admission: is it safe?A M Almaguer, K H Cichos, G McGwin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalK M Dougherty, J M Pearson, A Y Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the ratJ M Pearson, A E Schultze, K A Schwartz, et al.
British Medical Journal|January 21, 1978
Rifampicin for lepromatous leprosy: nine years' experienceM F Waters, R J Rees, J M Pearson, et al.
Leprosy Review|March 1, 1986
The effect of dapsone in high and normal dosage on the clinical and cell-mediated immune status of patients with borderline (BT-BL) leprosyS S Rao, J N Stanley, K U Kiran, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Clinical and Experimental Immunology|October 1, 1972
Evaluation of cell mediated immune responses in untreated cases of leprosyG P Talwar, A D Krishnan, V L Mehra, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 30, 2017
A Primer on Foraging and the Explore/Exploit Trade-Off for Psychiatry ResearchM A Addicott, J M Pearson, M M Sweitzer, et al.
Leprosy Review|December 1, 1977
Dapsone alone compared with dapsone plus rifampicin in short-term therapy of lepromatous leprosyR H Gelber, M F Waters, J M Pearson, et al.
International Journal of Leprosy and Other Mycobacterial Diseases : Official Organ of the International Leprosy Association|January 1, 1976
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studiesR J Rees, M F Waters, J M Pearson, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2004
Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinomaP D Ainsworth, J H R Winstanley, J M Pearson, et al.
The Bone & Joint Journal|May 1, 2019
Combined total hip and knee arthroplasty during the same hospital admission: is it safe?A M Almaguer, K H Cichos, G McGwin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalK M Dougherty, J M Pearson, A Y Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the ratJ M Pearson, A E Schultze, K A Schwartz, et al.
British Medical Journal|January 21, 1978
Rifampicin for lepromatous leprosy: nine years' experienceM F Waters, R J Rees, J M Pearson, et al.
Leprosy Review|March 1, 1986
The effect of dapsone in high and normal dosage on the clinical and cell-mediated immune status of patients with borderline (BT-BL) leprosyS S Rao, J N Stanley, K U Kiran, et al.
Pageof 11